🔗 Visit the ClinicalTrials.gov page for NCT00739830
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Emerging therapeutic targets in endometrial cancer. | Nat Rev Clin Oncol | 2011 | 1.99 |
| 2 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 3 | Molecular alterations of PI3K/Akt/mTOR pathway: a therapeutic target in endometrial cancer. | ScientificWorldJournal | 2014 | 0.90 |
| 4 | Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma. | J Clin Oncol | 2015 | 0.83 |
| 5 | Ridaforolimus. | Drugs R D | 2010 | 0.78 |